Gain Therapeutics, Inc.
GANX
$1.80
$0.063.45%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 10.39M | 12.05M | 16.94M | 12.66M | 16.79M |
| Total Receivables | 765.80K | 373.70K | 313.20K | 249.10K | 242.60K |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 450.90K | 1.32M | 1.29M | 952.90K | 741.60K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 11.60M | 13.74M | 18.54M | 13.86M | 17.78M |
|
|
|||||
| Total Current Assets | 11.60M | 13.74M | 18.54M | 13.86M | 17.78M |
| Net Property, Plant & Equipment | 323.30K | 401.20K | 449.80K | 496.10K | 585.20K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 134.30K | 156.30K | 158.10K | 169.20K | 193.40K |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 63.80K | 66.90K | 49.40K | 49.40K | 51.90K |
| Total Assets | 12.12M | 14.37M | 19.20M | 14.58M | 18.61M |
|
|
|||||
| Total Accounts Payable | 946.30K | 1.10M | 2.05M | 1.41M | 1.32M |
| Total Accrued Expenses | 2.42M | 2.47M | 3.42M | 2.29M | 2.11M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 271.10K | 297.10K | 297.90K | 315.40K | 348.50K |
| Total Finance Division Other Current Liabilities | 270.70K | 729.00K | 759.70K | 989.40K | 1.17M |
| Total Other Current Liabilities | 270.70K | 729.00K | 759.70K | 989.40K | 1.17M |
| Total Current Liabilities | 3.91M | 4.59M | 6.52M | 5.00M | 4.95M |
|
|
|||||
| Total Current Liabilities | 3.91M | 4.59M | 6.52M | 5.00M | 4.95M |
| Long-Term Debt | 328.30K | 376.10K | 375.40K | 396.80K | 449.10K |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 53.60K | 96.20K | 134.30K | 177.40K | 229.90K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 491.10K | 389.10K | 378.80K | 356.80K | 402.20K |
| Total Liabilities | 4.78M | 5.46M | 7.41M | 5.94M | 6.03M |
|
|
|||||
| Common Stock & APIC | 88.78M | 86.09M | 84.71M | 73.42M | 73.11M |
| Retained Earnings | -81.19M | -77.43M | -72.94M | -64.80M | -60.78M |
| Treasury Stock & Other | -247.50K | 242.80K | 12.50K | 21.90K | 247.20K |
| Total Common Equity | 7.34M | 8.91M | 11.78M | 8.64M | 12.58M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 7.34M | 8.91M | 11.78M | 8.64M | 12.58M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 7.34M | 8.91M | 11.78M | 8.64M | 12.58M |
|
|
|||||